Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: February 2026

Why Is Cardiovascular Disease Risk Higher in Women?

February 12, 2026 by sugaradmin

Share on PinterestHeart disease is the leading cause of death for both males and females, despite the myth that heart disease is a “man’s disease.” Marco Govel/Stocksy Most women are unaware of their heart disease risks. The myth that heart disease is a ‘man’s disease’ is inaccurate as heart disease is the number one cause […]

Read More
Health NewsLeave a Comment on Why Is Cardiovascular Disease Risk Higher in Women?

Hair Extensions May Contain Cancer-Causing Chemicals, Study Finds

February 11, 2026 by sugaradmin

Share on PinterestRecent research has found that many hair extensions may contain chemicals that are linked to cancer. Image Credit: Vera Lair/Stocksy A new study has found that many types of hair extensions contain chemicals linked to cancer. A chemical banned from boat paint because it’s too toxic for fish is allowed in products worn […]

Read More
Health NewsLeave a Comment on Hair Extensions May Contain Cancer-Causing Chemicals, Study Finds

High-Quality Low Carb, Low Fat Diet May Lower Cardiovascular Risk

February 11, 2026 by sugaradmin

Share on PinterestNew research indicates that diet quality matters for cardiovascular health. Nikolay_Donetsk/Getty Images The quality of a low carb or low fat diet may be more important for heart health than the amount of fat and carbohydrates consumed. Healthy versions of low fat and low carb diets that prioritized plant-based foods, whole grains, and […]

Read More
Health NewsLeave a Comment on High-Quality Low Carb, Low Fat Diet May Lower Cardiovascular Risk

Feasibility and cost-effectiveness of at-home self-sampling screening for type 2 diabetes: a pilot screening study in Denmark

February 11, 2026 by sugaradmin

Objective The increased use of HbA1c as a diagnostic criterion, novel methods to collect and store blood samples as well as the quality of national registers enable screening targeted individuals, who are not screened opportunistically. The study evaluates whether screening for type 2 diabetes using at-home self-sampling HbA1c tests, targeted people who have not had […]

Read More
Health NewsLeave a Comment on Feasibility and cost-effectiveness of at-home self-sampling screening for type 2 diabetes: a pilot screening study in Denmark

Hair Extensions May Contain Cancer-Causing Chemicals, Study Finds

February 11, 2026 by sugaradmin

Share on PinterestRecent research has found that many hair extensions may contain chemicals that are linked to cancer. Image Credit: Vera Lair/Stocksy A new study has found that many types of hair extensions contain chemicals linked to cancer. A chemical banned from boat paint because it’s too toxic for fish is allowed in products worn […]

Read More
Health NewsLeave a Comment on Hair Extensions May Contain Cancer-Causing Chemicals, Study Finds

EPCs-derived exosomal miR-7116-3p alleviate high glucose-induced endothelial cell dysfunction by targeting Orai1-IGFBP3 complexes

February 11, 2026 by sugaradmin

Introduction Diabetic vascular complications are predominantly caused by high glucose (HG)-induced endothelial dysfunction. Exosomes derived from endothelial progenitor cells (EPCs-EXOs) have shown therapeutic potential by modulating cellular functions through the delivery of bioactive cargos, particularly microRNAs (miRNAs). This study examines the role of EPCs-EXOs and their miRNA cargo in mitigating HG-induced endothelial dysfunction by targeting […]

Read More
Health NewsLeave a Comment on EPCs-derived exosomal miR-7116-3p alleviate high glucose-induced endothelial cell dysfunction by targeting Orai1-IGFBP3 complexes

Special Edition – Oral GLP-1 Receptor Agonist

February 11, 2026 by sugaradmin

In this special series on Oral GLP-1 Receptor Agonists, Dr. Neil Skolnik will discuss the first of the GLP-1 RAs to receive FDA approval, Semaglutide. This special episode is supported by an independent educational grant from Novo. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; […]

Read More
DiabetesLeave a Comment on Special Edition – Oral GLP-1 Receptor Agonist

Aerobic Exercise Highly Effective for Depression and Anxiety: Study

February 11, 2026 by sugaradmin

Share on PinterestA new study found that aerobic exercise may be as effective as standard treatments for depression and anxiety. Christine La/Stocksy A new study found that aerobic exercise can be highly effective for reducing symptoms of depression and anxiety, with benefits comparable to standard treatments. Group-based exercise provides the strongest relief for depression, offering […]

Read More
Health NewsLeave a Comment on Aerobic Exercise Highly Effective for Depression and Anxiety: Study

FDA Blocks Hims & Hers $49 Compounded Wegovy Pill: What to Know

February 11, 2026 by sugaradmin

Share on PinterestHims & Hers has withdrawn its low cost compounded weight loss pill after pressure from top U.S. health officials and a major lawsuit. Image courtesy of Novo Nordisk Hims & Hers recently announced a $49 compounded semaglutide pill, offering a low cost alternative to the new Wegovy pill. However, the compounded version was […]

Read More
Health NewsLeave a Comment on FDA Blocks Hims & Hers $49 Compounded Wegovy Pill: What to Know

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes

February 10, 2026 by sugaradmin

Background There is growing interest in widening the use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) to all people with type 2 diabetes mellitus (T2DM). However, pivotal randomized controlled trials (RCTs) evaluated these drugs only in highly selected populations, often lacking generalizability to real-world populations. Understanding the effects of SGLT2i in populations where RCT evidence may […]

Read More
Health NewsLeave a Comment on Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes

Posts navigation

Older posts
Newer posts

Recent Posts

  • Fructose in Ultra-Processed Foods May Raise Metabolic Disease
  • Trump Reclassifies Marijuana as Less Dangerous in Major Policy Shift
  • Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62%
  • FDA Issues Nationwide Recall of ‘Extended Release’ Xanax for Anxiety
  • Viral ‘Egg Coffee’ Drink May Pose Food Safety Risk

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness